Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
Despite the hundreds of millions of vials of blood drawn every year for medical testing, scientists have only scratched the surface of its diagnostic potential. The blood proteome — which includes all ...
Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and confirms atomically precise binding using high-resolution molecular imaging, ...
Antibodies are one of the most specific tools for the detection and capture of molecular targets. The right antibody can play a key role in revealing the presence, quantity, dynamics, and even ...
A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses ...
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
CSL has gotten the Memo about the value of recombinant polyclonal immunoglobulin (IgG) antibodies. The company is signing on to a collaboration and option agreement with Memo Therapeutics that could ...
Antibodies are Y-shaped protective proteins manufactured by B lymphocytes in reaction to invading pathogens. When B lymphocytes encounter foreign antigens expressed by antigen-presenting cells (e.g.
Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are highly specific to an antigen. By fusing myeloma cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results